GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DHG Pharmaceutical JSC (STC:DHG) » Definitions » Cyclically Adjusted Revenue per Share

DHG Pharmaceutical JSC (STC:DHG) Cyclically Adjusted Revenue per Share : ₫36,697.40 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is DHG Pharmaceutical JSC Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DHG Pharmaceutical JSC's adjusted revenue per share for the three months ended in Dec. 2023 was ₫11,738.220. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₫36,697.40 for the trailing ten years ended in Dec. 2023.

During the past 12 months, DHG Pharmaceutical JSC's average Cyclically Adjusted Revenue Growth Rate was 3.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DHG Pharmaceutical JSC was 6.20% per year. The lowest was 6.20% per year. And the median was 6.20% per year.

As of today (2024-05-26), DHG Pharmaceutical JSC's current stock price is ₫117400.00. DHG Pharmaceutical JSC's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₫36,697.40. DHG Pharmaceutical JSC's Cyclically Adjusted PS Ratio of today is 3.20.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DHG Pharmaceutical JSC was 3.89. The lowest was 2.29. And the median was 3.03.


DHG Pharmaceutical JSC Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for DHG Pharmaceutical JSC's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DHG Pharmaceutical JSC Cyclically Adjusted Revenue per Share Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 30,636.50 32,591.00 35,346.00 36,697.40

DHG Pharmaceutical JSC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35,346.00 36,188.00 36,423.50 36,745.60 36,697.40

Competitive Comparison of DHG Pharmaceutical JSC's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DHG Pharmaceutical JSC's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DHG Pharmaceutical JSC's Cyclically Adjusted PS Ratio falls into.



DHG Pharmaceutical JSC Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DHG Pharmaceutical JSC's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=11738.22/129.4194*129.4194
=11,738.220

Current CPI (Dec. 2023) = 129.4194.

DHG Pharmaceutical JSC Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 7,421.035 99.695 9,633.690
201406 7,412.784 100.560 9,540.203
201409 6,948.495 100.428 8,954.394
201412 10,028.699 99.070 13,100.960
201503 5,118.016 99.621 6,648.898
201506 6,110.543 100.684 7,854.511
201509 7,585.687 100.392 9,779.066
201512 8,808.700 99.792 11,423.883
201603 6,252.542 100.470 8,054.116
201606 6,709.287 101.688 8,538.973
201609 7,023.059 101.861 8,923.141
201612 8,987.610 101.863 11,419.009
201703 10,123.072 102.862 12,736.670
201706 7,080.120 103.349 8,866.114
201709 6,899.043 104.136 8,574.109
201712 10,345.758 104.011 12,873.066
201803 6,948.044 105.290 8,540.374
201806 6,346.492 106.317 7,725.582
201809 5,630.815 106.507 6,842.168
201812 8,288.346 105.998 10,119.755
201903 5,864.717 107.251 7,076.966
201906 7,579.852 108.070 9,077.306
201909 6,405.122 108.329 7,652.097
201912 9,418.797 108.420 11,243.073
202003 6,565.833 108.902 7,802.888
202006 6,033.511 108.767 7,179.119
202009 6,360.377 109.815 7,495.851
202012 8,924.917 109.897 10,510.382
202103 7,781.376 111.754 9,011.377
202106 6,976.770 114.631 7,876.807
202109 6,952.868 115.734 7,775.016
202112 8,363.501 117.630 9,201.767
202203 8,143.847 121.301 8,688.896
202206 8,283.442 125.017 8,575.152
202209 8,602.399 125.227 8,890.429
202212 10,174.602 125.222 10,515.668
202303 9,396.525 127.348 9,549.381
202306 8,815.948 128.729 8,863.250
202309 8,129.648 129.860 8,102.096
202312 11,738.220 129.419 11,738.220

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


DHG Pharmaceutical JSC  (STC:DHG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DHG Pharmaceutical JSC's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=117400.00/36697.4
=3.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DHG Pharmaceutical JSC was 3.89. The lowest was 2.29. And the median was 3.03.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DHG Pharmaceutical JSC Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of DHG Pharmaceutical JSC's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


DHG Pharmaceutical JSC (STC:DHG) Business Description

Industry
Traded in Other Exchanges
N/A
Address
288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotic, antifungal, and antiparasitic; analgesic and antipyretic; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.

DHG Pharmaceutical JSC (STC:DHG) Headlines